Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic (“IVD”) device in the UK and Europe: the GridION™ Dx
Oxford Nanopore GridION™ Dx Achieves CE and UKCA Certification
Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company’s first IVD device registered in the UK and Europe. This certification confirms the device meets strict international standards for quality, safety, and performance. GridION™ Dx is poised for adoption in regulated clinical markets, reflecting Oxford Nanopore’s commitment to sequencing-based diagnostics.
Learn More: https://lnkd.in/enCDeCVv
